ataraxis-ai
Develops AI-native tools for cancer prognosis and treatment selection.
OncologyHealthcare Technology
Company facts
Series A-stage
- Founded
- 2022
- Employees
- 29
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $20.4M · 2025
Develops AI-native tools for cancer prognosis and treatment selection.
Company facts